Montironi R - Search Results

1

The landscape of EGFR pathways and personalized management of non-small-cell lung cancer.

Cheng L, Zhang S, Alexander R, Yao Y, MacLennan GT, Pan CX, Huang J, Wang M, Montironi R, Lopez-Beltran A. Cheng L, et al. Among authors: montironi r. Future Oncol. 2011 Apr;7(4):519-41. doi: 10.2217/fon.11.25. Future Oncol. 2011. PMID: 21463141 Review.

2

Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation.

Lopez-Beltran A, Cheng L, Andersson L, Brausi M, de Matteis A, Montironi R, Sesterhenn I, van det Kwast KT, Mazerolles C. Lopez-Beltran A, et al. Among authors: montironi r. Virchows Arch. 2002 Jan;440(1):3-11. doi: 10.1007/s00428-001-0577-6. Virchows Arch. 2002. PMID: 11942574 Review.

3

Evaluation of prognostic factors in radical prostatectomy specimens with cancer.

Mazzucchelli R, Santinelli A, Lopez-Beltran A, Scarpelli M, Montironi R. Mazzucchelli R, et al. Among authors: montironi r. Urol Int. 2002;68(4):209-15. doi: 10.1159/000058437. Urol Int. 2002. PMID: 12053019 Review.

4

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.

Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R. Lopez-Beltran A, et al. Among authors: montironi r. Eur Urol. 2004 Mar;45(3):257-66. doi: 10.1016/j.eururo.2003.09.018. Eur Urol. 2004. PMID: 15036668 Review.

5

Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptors.

Montironi R, Scarpelli M, López Beltran A. Montironi R, et al. Virchows Arch. 2004 Jun;444(6):503-8. doi: 10.1007/s00428-004-0996-2. Epub 2004 Mar 26. Virchows Arch. 2004. PMID: 15045584 Review.

6

Non-invasive urothelial neoplasms: according to the most recent WHO classification.

Lopez-Beltran A, Montironi R. Lopez-Beltran A, et al. Among authors: montironi r. Eur Urol. 2004 Aug;46(2):170-6. doi: 10.1016/j.eururo.2004.03.017. Eur Urol. 2004. PMID: 15245809 Review.

7

Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.

Lopez-Beltran A, Luque RJ, Alvarez-Kindelan J, Quintero A, Merlo F, Requena MJ, Montironi R. Lopez-Beltran A, et al. Among authors: montironi r. Am J Clin Pathol. 2004 Sep;122(3):444-52. doi: 10.1309/LTFU-3UUM-BY09-5HUM. Am J Clin Pathol. 2004. PMID: 15362377

8

The 2004 WHO classification of bladder tumors: a summary and commentary.

Montironi R, Lopez-Beltran A. Montironi R, et al. Int J Surg Pathol. 2005 Apr;13(2):143-53. doi: 10.1177/106689690501300203. Int J Surg Pathol. 2005. PMID: 15864376 Review.

9

Atypical adenomatous hyperplasia (adenosis) of the prostate: DNA ploidy analysis and immunophenotype.

Lopez-Beltran A, Qian J, Montironi R, Luque RJ, Bostwick DG. Lopez-Beltran A, et al. Among authors: montironi r. Int J Surg Pathol. 2005 Apr;13(2):167-73. doi: 10.1177/106689690501300207. Int J Surg Pathol. 2005. PMID: 15864380

10

Current practice of Gleason grading of prostate carcinoma.

Lopez-Beltran A, Mikuz G, Luque RJ, Mazzucchelli R, Montironi R. Lopez-Beltran A, et al. Among authors: montironi r. Virchows Arch. 2006 Feb;448(2):111-8. doi: 10.1007/s00428-005-0102-4. Epub 2005 Nov 23. Virchows Arch. 2006. PMID: 16328356 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,016 results

Search Page